4.4 Article

Trophoblast Cell Surface Antigen 2 Expression in Human Tumors: A Tissue Microarray Study on 18,563 Tumors

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Pharmacology & Pharmacy

Sacituzumab Govitecan-hziy: An Antibody-Drug Conjugate for the Treatment of Refractory, Metastatic, Triple-Negative Breast Cancer

John M. Seligson et al.

Summary: This review examines the pharmacology, efficacy, and safety of sacituzumab govitecan for patients with metastatic triple-negative breast cancer who have received at least 2 prior therapies. Sacituzumab govitecan is an antibody-drug conjugate with promising activity in mTNBC, evidenced by accelerated FDA approval based on a phase I/II study. Common adverse reactions include nausea, neutropenia, and diarrhea, with ongoing confirmatory clinical trials.

ANNALS OF PHARMACOTHERAPY (2021)

Review Biotechnology & Applied Microbiology

Targeting Trop-2 in solid tumors: future prospects

Saif Zaman et al.

ONCOTARGETS AND THERAPY (2019)

Review Oncology

Antibody Based EpCAM Targeted Therapy of Cancer, Review and Update

Shirin Eyvazil et al.

CURRENT CANCER DRUG TARGETS (2018)

Review Biochemistry & Molecular Biology

EpCAM: Structure and function in health and disease

Ulrike Schnell et al.

BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2013)

Editorial Material Genetics & Heredity

The Genotype-Tissue Expression (GTEx) project

John Lonsdale et al.

NATURE GENETICS (2013)

Review Biochemistry & Molecular Biology

Trop2: A possible therapeutic target for late stage epithelial carcinomas

Rafael Cubas et al.

BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2009)

Review Pathology

Epithelial cell adhesion molecule - More than a carcinoma marker and adhesion molecule

Monika Trzpis et al.

AMERICAN JOURNAL OF PATHOLOGY (2007)